Literature DB >> 20507231

Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Andrew Hollands1, Morgan A Pence, Anjuli M Timmer, Sarah R Osvath, Lynne Turnbull, Cynthia B Whitchurch, Mark J Walker, Victor Nizet.   

Abstract

BACKGROUND: The recent resurgence of invasive group A streptococcal disease has been paralleled by the emergence of the M1T1 clone. Recently, invasive disease initiation has been linked to mutations in the covR/S 2-component regulator. We investigated whether a fitness cost is associated with the covS mutation that counterbalances hypervirulence.
METHODS: Wild-type M1T1 group A Streptococcus and an isogenic covS-mutant strain derived from animal passage were compared for adherence to human laryngeal epithelial cells, human keratinocytes, or fibronectin; biofilm formation; and binding to intact mouse skin. Targeted mutagenesis of capsule expression of both strains was performed for analysis of its unique contribution to the observed phenotypes.
RESULTS: The covS-mutant bacteria showed reduced capacity to bind to epithelial cell layers as a consequence of increased capsule expression. The covS-mutant strain also had reduced capacity to bind fibronectin and to form biofilms on plastic and epithelial cell layers. A defect in skin adherence of the covS-mutant strain was demonstrated in a murine model.
CONCLUSION: Reduced colonization capacity provides a potential explanation for why the covS mutation, which confers hypervirulence, has not become fixed in the globally disseminated M1T1 group A Streptococcus clone, but rather may arise anew under innate immune selection in individual patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507231      PMCID: PMC2880657          DOI: 10.1086/653124

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

1.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Role of group A Streptococcus HtrA in the maturation of SpeB protease.

Authors:  Jason N Cole; John A Aquilina; Peter G Hains; Anna Henningham; Kadaba S Sriprakash; Michael G Caparon; Victor Nizet; Malak Kotb; Stuart J Cordwell; Steven P Djordjevic; Mark J Walker
Journal:  Proteomics       Date:  2007-12       Impact factor: 3.984

3.  A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties.

Authors:  R Raeder; M Woischnik; A Podbielski; M D Boyle
Journal:  Res Microbiol       Date:  1998-09       Impact factor: 3.992

4.  Genetic locus for streptolysin S production by group A streptococcus.

Authors:  V Nizet; B Beall; D J Bast; V Datta; L Kilburn; D E Low; J C De Azavedo
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 5.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

6.  Group A Streptococcus tissue invasion by CD44-mediated cell signalling.

Authors:  C Cywes; M R Wessels
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

Review 7.  Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

Authors:  Mark J Walker; Jason D McArthur; Fiona McKay; Marie Ranson
Journal:  Trends Microbiol       Date:  2005-07       Impact factor: 17.079

8.  Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.

Authors:  H M Schrager; S Albertí; C Cywes; G J Dougherty; M R Wessels
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

9.  Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

Authors:  Ramy K Aziz; Michael J Pabst; Arthur Jeng; Rita Kansal; Donald E Low; Victor Nizet; Malak Kotb
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

10.  The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.

Authors:  Annelies S Zinkernagel; Anjuli M Timmer; Morgan A Pence; Jeffrey B Locke; John T Buchanan; Claire E Turner; Inbal Mishalian; Shiranee Sriskandan; Emanuel Hanski; Victor Nizet
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

View more
  63 in total

1.  Group A Streptococcus Infection of the Nasopharynx Requires Proinflammatory Signaling through the Interleukin-1 Receptor.

Authors:  Doris L LaRock; Raedeen Russell; Anders F Johnson; Shyra Wilde; Christopher N LaRock
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Characterization of the effect of the histidine kinase CovS on response regulator phosphorylation in group A Streptococcus.

Authors:  Nicola Horstmann; Pranoti Sahasrabhojane; Miguel Saldaña; Nadim J Ajami; Anthony R Flores; Paul Sumby; Chang-Gong Liu; Hui Yao; Xiaoping Su; Erika Thompson; Samuel A Shelburne
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

3.  RocA Is an Accessory Protein to the Virulence-Regulating CovRS Two-Component System in Group A Streptococcus.

Authors:  Ira Jain; Eric W Miller; Jessica L Danger; Kathryn J Pflughoeft; Paul Sumby
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

4.  Biofilm in group A streptococcal necrotizing soft tissue infections.

Authors:  Nikolai Siemens; Bhavya Chakrakodi; Srikanth Mairpady Shambat; Marina Morgan; Helena Bergsten; Ole Hyldegaard; Steinar Skrede; Per Arnell; Martin B Madsen; Linda Johansson; Julius Juarez; Lidija Bosnjak; Matthias Mörgelin; Mattias Svensson; Anna Norrby-Teglund
Journal:  JCI Insight       Date:  2016-07-07

5.  Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.

Authors:  James A Tsatsaronis; Andrew Hollands; Jason N Cole; Peter G Maamary; Christine M Gillen; Nouri L Ben Zakour; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker; Martina L Sanderson-Smith
Journal:  FASEB J       Date:  2013-03-26       Impact factor: 5.191

Review 6.  RNA-mediated regulation in Gram-positive pathogens: an overview punctuated with examples from the group A Streptococcus.

Authors:  Eric W Miller; Tram N Cao; Kathryn J Pflughoeft; Paul Sumby
Journal:  Mol Microbiol       Date:  2014-08-21       Impact factor: 3.501

7.  Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence.

Authors:  Ramy K Aziz; Rita Kansal; Bruce J Aronow; William L Taylor; Sarah L Rowe; Michael Kubal; Gursharan S Chhatwal; Mark J Walker; Malak Kotb
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  Allelic replacement of the streptococcal cysteine protease SpeB in a Δsrv mutant background restores biofilm formation.

Authors:  Amity L Roberts; Robert C Holder; Sean D Reid
Journal:  BMC Res Notes       Date:  2010-11-04

9.  Screening of in vivo activated genes in Enterococcus faecalis during insect and mouse infections and growth in urine.

Authors:  Aurelie Hanin; Irina Sava; YinYin Bao; Johannes Huebner; Axel Hartke; Yanick Auffray; Nicolas Sauvageot
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

10.  The streptococcal hemoprotein receptor: a moonlighting protein or a virulence factor?

Authors:  Zehava Eichenbaum
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.